Menu
Back to Journals » Journal of Inflammation Research » Volume 14
Increased Leptin/Leptin Receptor Pathway Affects Systemic and Airway Inflammation in COPD Former Smokers [Retraction]
Authors Bruno A, Alessi M, Soresi S, Bonanno A, Riccobono L, Montalbano AM, Albano GD, Gjomarkaj M, Profita M
Received 9 December 2021
Accepted for publication 9 December 2021
Published 14 December 2021 Volume 2021:14 Pages 6855—6856
Bruno A, Alessi M, Soresi S, et al. J Inflamm Res. 2011;4:51–59.
The Editor and Publisher of Journal of Inflammation Research wish to retract the published article. Concerns were raised regarding the duplication of images in Figure 3 describing leptin receptor expression with those from an article published by the authors several years previously describing muscarinic receptor expression. Specifically:
- Figure 3A, Leptin receptor expression, Smokers, appears to have been duplicated with Figure 2 panel M3 COPD, for the expression of muscarinic receptors.
- Figure 3D, Leptin expression, Smokers, appears to have been duplicated with Figure 2 panel M1 Smokers, for the expression of muscarinic receptors.
- Figure 3A, Leptin receptor expression, Smokers, appears to share duplicated elements with Figure 3D, Leptin expression, Smokers.
The authors did not respond to our queries and the Editor advised for the article to be retracted.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.